Can fenofibrate cause diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Fenofibrate Cause Diarrhea?

Yes, fenofibrate can cause diarrhea, though it is generally considered a mild and infrequent adverse effect.

Evidence from FDA Drug Labeling

According to the FDA-approved prescribing information, diarrhea is listed as a recognized adverse effect of fenofibrate 1. The drug label specifically identifies diarrhea among the adverse effects observed with fenofibrate monotherapy, as well as when used in combination with statin therapy 2.

Clinical Significance and Frequency

The occurrence of diarrhea with fenofibrate appears to be:

  • Generally mild in severity - In a veterinary study that evaluated fenofibrate safety (which provides additional safety data), only 3% of subjects experienced diarrhea, and it was not considered a significant adverse effect requiring treatment discontinuation 3

  • Well-tolerated overall - The FDA labeling notes that fenofibrate is "generally well tolerated," suggesting that gastrointestinal side effects like diarrhea do not typically limit its clinical use 1

Clinical Context

When fenofibrate is used in combination with ezetimibe, diarrhea is also listed among the adverse effects of the combination therapy 2. This suggests the gastrointestinal effect is consistent across different treatment regimens.

The key clinical takeaway is that while diarrhea can occur with fenofibrate, it is typically mild and self-limiting, and should not routinely prevent the use of this medication when indicated for severe hypertriglyceridemia or mixed dyslipidemia. If diarrhea becomes problematic, consider dose adjustment or symptomatic management before discontinuing therapy, given fenofibrate's established benefits in lipid management.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.